CD4 and lymphopenia: ▪MAC infections have been documented among HSCT recipients, manifesting as cutaneous, pulmonary, or catheter-associated infections [101]▪For those with prolonged CD4+ lymphopenia who will be at risk of developing MAC, primary prophylaxis remains indicated.